Venous Thrombosis and Thromboembolism: Advanced Performance Protocols and Interpretation and Updates on Medical and Interventional Disease Management, Part 1 Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients.	The skills learned in this CME course will be applied in the treatment of my patients. - 5	The skills learned in this CME course will be applied in the treatment of my patients. - 4	The skills learned in this CME course will be applied in the treatment of my patients. - 3	The skills learned in this CME course will be applied in the treatment of my patients. - 2	The skills learned in this CME course will be applied in the treatment of my patients. - 1	The skills learned in this CME course will be applied in the treatment of my patients. - NA

As a result of attending this conference, to what extent do you agree that you will be better able to: (rate the objectives) *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
Recognize the prevalence of DVT and VTE in the United States.	Recognize the prevalence of DVT and VTE in the United States. - 5	Recognize the prevalence of DVT and VTE in the United States. - 4	Recognize the prevalence of DVT and VTE in the United States. - 3	Recognize the prevalence of DVT and VTE in the United States. - 2	Recognize the prevalence of DVT and VTE in the United States. - 1	Recognize the prevalence of DVT and VTE in the United States. - NA
Identify acquired and inherited risk factor and Virchow triad.	Identify acquired and inherited risk factor and Virchow triad. - 5	Identify acquired and inherited risk factor and Virchow triad. - 4	Identify acquired and inherited risk factor and Virchow triad. - 3	Identify acquired and inherited risk factor and Virchow triad. - 2	Identify acquired and inherited risk factor and Virchow triad. - 1	Identify acquired and inherited risk factor and Virchow triad. - NA
Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay.	Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay. - 5	Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay. - 4	Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay. - 3	Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay. - 2	Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay. - 1	Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay. - NA
Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE.	Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE. - 5	Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE. - 4	Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE. - 3	Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE. - 2	Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE. - 1	Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE. - NA
Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations.	Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations. - 5	Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations. - 4	Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations. - 3	Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations. - 2	Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations. - 1	Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations. - NA
Recognize the appropriate management for calf vein thrombosis.	Recognize the appropriate management for calf vein thrombosis. - 5	Recognize the appropriate management for calf vein thrombosis. - 4	Recognize the appropriate management for calf vein thrombosis. - 3	Recognize the appropriate management for calf vein thrombosis. - 2	Recognize the appropriate management for calf vein thrombosis. - 1	Recognize the appropriate management for calf vein thrombosis. - NA
Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management.	Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management. - 5	Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management. - 4	Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management. - 3	Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management. - 2	Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management. - 1	Define ilio-femoral and femoro-popliteal DVT and explain its medical disease management. - NA
Explain oral anticoagulation vs. systemic heparin.	Explain oral anticoagulation vs. systemic heparin. - 5	Explain oral anticoagulation vs. systemic heparin. - 4	Explain oral anticoagulation vs. systemic heparin. - 3	Explain oral anticoagulation vs. systemic heparin. - 2	Explain oral anticoagulation vs. systemic heparin. - 1	Explain oral anticoagulation vs. systemic heparin. - NA

How satisfied or dissatisfied were you with the following conference content? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Lecture materials.	Lecture materials. - 5	Lecture materials. - 4	Lecture materials. - 3	Lecture materials. - 2	Lecture materials. - 1
Speaker's effectiveness in addressing the learning objectives.	Speaker's effectiveness in addressing the learning objectives. - 5	Speaker's effectiveness in addressing the learning objectives. - 4	Speaker's effectiveness in addressing the learning objectives. - 3	Speaker's effectiveness in addressing the learning objectives. - 2	Speaker's effectiveness in addressing the learning objectives. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so?

Please provide any additional comments or suggestions.

Name

You are here

Venous Thrombosis and Thromboembolism: Advanced Performance Protocols and Interpretation and Updates on Medical and Interventional Disease Management, Part 1 Evaluation